KENYON JULIAN NORMAN (Chief Scientific Officer) received a stock award from PROPANC BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/20/2021ACC: 0001493152-21-020759
DirectorOfficer· Chief Scientific Officer
Since May 2019
+3.42M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
3.42M acquired
Non-Derivative Transactions1
Common stock, par value $0.001
Direct
Shares
+3.42M
Price / share
—
Trade value
—
% of position
68400000.0%
8/17/2021
5.00→3.42M
Total
Net shares
+3.42M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 Direct | 8/17/2021 | A · Award | +3.42M | — | — | 68400000.0% | 5.00 | 3.42M |
| Total | +3.42M | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported